Precision Medicine Online

Precision Medicine Online Precision Medicine Online is published by GenomeWeb, an independent online news organization.

The firm's antibody-drug conjugate Trodelvy performed well amid overall oncology losses.
10/31/2025

The firm's antibody-drug conjugate Trodelvy performed well amid overall oncology losses.

The Midwest hospital system aims to embed genetic testing into everyday care for heart disease and discover new genetic ...
10/31/2025

The Midwest hospital system aims to embed genetic testing into everyday care for heart disease and discover new genetic risk factors.

The company's outlook for the rest of the year was rosier than in the previous quarter, when it announced cost-cutting p...
10/30/2025

The company's outlook for the rest of the year was rosier than in the previous quarter, when it announced cost-cutting plan and layoffs.

The agency said the move could halve the time it takes for biosimilars to enter the market, drive competition, and reduc...
10/30/2025

The agency said the move could halve the time it takes for biosimilars to enter the market, drive competition, and reduce prices.

The hospital system is betting the move will give it better control over turnaround time and allow it to be more "nimble...
10/29/2025

The hospital system is betting the move will give it better control over turnaround time and allow it to be more "nimble" in its work.

The firm is betting that treatments from new acquisitions, including its recent $12B bid for Avidity Biosciences, will s...
10/28/2025

The firm is betting that treatments from new acquisitions, including its recent $12B bid for Avidity Biosciences, will support long-term growth.

A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, l...
10/24/2025

A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely pathogenic variant.

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.
10/23/2025

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.

In the small first-in-human study, AB-1002 showed an encouraging safety profile and early signs of efficacy, investigato...
10/22/2025

In the small first-in-human study, AB-1002 showed an encouraging safety profile and early signs of efficacy, investigators report in Nature Medicine.

In two Phase I trials, researchers safely administered CAR T cells to high-grade glioma patients and are exploring ways ...
10/21/2025

In two Phase I trials, researchers safely administered CAR T cells to high-grade glioma patients and are exploring ways to bolster efficacy and predict responders.

The company will hold off on making a regulatory decision until it sees results from another trial testing the drug with...
10/21/2025

The company will hold off on making a regulatory decision until it sees results from another trial testing the drug with chemo and Opdivo.

The registrational trial of AD04 could launch as early as mid-2026, if the company is able to shore up necessary funds o...
10/20/2025

The registrational trial of AD04 could launch as early as mid-2026, if the company is able to shore up necessary funds or find a development partner.

Address

New York, NY

Telephone

+12122694747

Website

Alerts

Be the first to know and let us send you an email when Precision Medicine Online posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Precision Medicine Online:

Shortcuts

Share

Category